{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:09Z","timestamp":1747207329488,"version":"3.40.5"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Bronchial asthma and chronic obstructive pulmonary disease (COPD) are\namong the most common chronic diseases. Roflumilast is a novel, potent, selective, and long-acting\nphosphodiesterase 4 (PDE-4) inhibitor for the treatment of bronchial asthma and COPD. It has\nanti-inflammatory effects, and it has been shown to reduce exacerbations and improve pulmonary\nfunction in patients with COPD. Although there have been some other analytical methodologies reported\nfor the determination of roflumilast in pharmaceutical dosage forms, there has not yet been\nany electrochemical methodology proposed for determination of this unique active pharmaceutical\ningredient in its dosage forms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study was to develop an easily applied, selective, sensitive, accurate,\nand precise square-wave stripping voltammetric (SWSV) method for the determination of roflumilast\nin its pharmaceutical dosage forms. In addition, the electrochemical behavior of roflumilast\nwas investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> The proposed method was based on electrochemical reductioThe proposed method was based on electrochemical reduction of roflumilast at a hanging\nmercury drop electrode (HMDE) in 0.1 M K2HPO4 and 0.1 M Na2B4O7 (1:1, v\/v) buffer at pH\n5.0. Two reduction peaks were observed at -1150 mV and -1260 mV with 30 s of accumulation\ntime and -850 mV of accumulation potential time versus Ag\/AgCl reference electrode.n of roflumilast at a hanging mercury drop electrode\n(HMDE) in 0.1 M K2HPO4 and 0.1 M Na2B4O7 (1:1, v\/v) buffer at pH 5.0. Two reduction peaks were observed at -1150 mV\nand -1260 mV with 30 s of accumulation time and -850 mV of accumulation potential time versus Ag\/AgCl reference\nelectrode.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The higThe highest peak current values with the best peak definition were observed at a frequency\nof 50 Hz, scan increment of 5 mV, and pulse amplitude 25 mV. The proposed method was validated\nby evaluating validation parameters such as linearity, sensitivity, repeatability, accuracy, precision,\nselectivity, recovery, robustness, and ruggedness. A good linear correlation (r=0.9948) was\nobtained between the electrochemical response of roflumilast and its concentration in the range of\n0.74-3.05 \u03bcg mL-1 under the optimum conditions. The obtained accuracy results were between\n2.04% and -2.04% while the relative standard deviation of the results was at least 2.78% for intraday\nand inter-day studies. The mean recovery for the real applications was 100.63% \u00b1 0.52. The\nelectrochemical behavior of roflumilast was investigated by cyclic voltammetry. The cyclic voltammogram\nof roflumilast exhibited two peaks and the reduction reaction was reversible.hest peak current values with the best peak definition were observed at a frequency of 50 Hz, scan\nincrement of 5 mV, and pulse amplitude 25 mV. The proposed method was validated by evaluating validation parameters\nsuch as linearity, sensitivity, repeatability, accuracy, precision, selectivity, recovery, robustness, and ruggedness. A good\nlinear correlation (r=0.9948) was obtained between the electrochemical response of roflumilast and its concentration in the\nrange of 0.74-3.05 \u00b5g mL-1 under the optimum conditions. The obtained accuracy results were between 2.04% and -2.04%\nwhile the relative standard deviation of the results was at least 2.78% for intra-day and inter-day studies. Mean recovery for\nthe real applications was 100.63% \u00b1 0.52%. The electrochemical behavior of roflumilast was investigated by cyclic\nvoltammetry. The cyclic voltammogram of roflumilast exhibited two peaks and the reduction reaction was reversible.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This developed and validated SWSV method was applied successfully for the determination\nof roflumilast in tablet dosage form (Daxas\u00ae) to assess active roflumilast content. Since high-\n-performance liquid chromatography is a dominant technique in industry for quality control of active\npharmaceutical ingredients, the finding in the present study demonstrated that square-wave\nstripping voltammetry could be easily utilized in routine applications to determine roflumilast content\nin its dosage forms.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207323666200901102526","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T09:39:41Z","timestamp":1599039581000},"page":"400-408","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Electrochemical Behavior and Square-Wave Stripping Voltammetric Determination of Roflumilast in Pharmaceutical Dosage Forms"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-5512","authenticated-orcid":true,"given":"Mustafa","family":"\u00c7elebier","sequence":"first","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye 06100, Ankara,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-4697","authenticated-orcid":true,"given":"Aysegul","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye 06100, Ankara,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-2766","authenticated-orcid":true,"given":"\u0130ncilay","family":"S\u00fcsl\u00fc","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye 06100, Ankara,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-9218","authenticated-orcid":true,"given":"Sacide","family":"Alt\u0131n\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye 06100, Ankara,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00018-005-4533-5","volume":"62","author":"Jeon Y.H.","year":"2005","unstructured":"Jeon Y.H.; Heo Y.S.; Kim C.M.; Hyun Y.L.; Lee T.G.; Ro S.; Cho J.M.; Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005,62(11),1198-1220","journal-title":"Cell Mol Life Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1517\/13543784.17.5.811","volume":"17","author":"Field S.K.","year":"2008","unstructured":"Field S.K.; Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma. Expert Opin Investig Drugs 2008,17(5),811-818","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0091270006294529","volume":"47","author":"Bethke T.D.","year":"2007","unstructured":"Bethke T.D.; B\u00f6hmer G.M.; Hermann R.; Hauns B.; Fux R.; M\u00f6rike K.; David M.; Knoerzer D.; Wurst W.; Gleiter C.H.; Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J Clin Pharmacol 2007,47(1),26-36","journal-title":"J Clin Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1177\/0091270006291621","volume":"46","author":"Hauns B.","year":"2006","unstructured":"Hauns B.; Hermann R.; H\u00fcnnemeyer A.; Herzog R.; Hauschke D.; Zech K.; Bethke T.D.; Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects. J Clin Pharmacol 2006,46(10),1146-1153","journal-title":"J Clin Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/0091270007300950","volume":"47","author":"Hermann R.","year":"2007","unstructured":"Hermann R.; Siegmund W.; Giessmann T.; Westphal K.; Weinbrenner A.; Hauns B.; Reutter F.; Lahu G.; Zech K.; Bethke T.D.; The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. J Clin Pharmacol 2007,47(8),1005-1013","journal-title":"J Clin Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","volume":"374","author":"Fabbri L.M.","year":"2009","unstructured":"Fabbri L.M.; Calverley P.M.; Izquierdo-Alonso J.L.; Bundschuh D.S.; Brose M.; Martinez F.J.; Rabe K.F.; Grp M-S.; Grp M-S.; Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet M2-127 and M2-128 study groups2009,374(9691),695-703","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4103\/0250-474X.70496","volume":"72","author":"Barhate V.D.","year":"2010","unstructured":"Barhate V.D.; Deosthalee P.; Rapid liquid chromatographic method for the determination of roflumilast in the presence of degradation products. Indian J Pharm Sci 2010,72(3),401-404","journal-title":"Indian J Pharm Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4028\/www.scientific.net\/AMR.781-784.68","volume":"781-784","author":"Fang T.","year":"2013","unstructured":"Fang T.; Development and Validation of Stability-Indicating HPLC Method for Roflumilast and Related Substances. Adv Mat Res 2013,781-784,68-71","journal-title":"Adv Mat Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/10826076.2018.1436067","volume":"41","author":"Pinheiro M.","year":"2018","unstructured":"Pinheiro M.; Marins R.; Cabral L.; de Sousa V.; Development and validation of a RP-HPLC method for Roflumilast and its degradation products. J Liq Chromatogr Relat Technol 2018,41(5),223-231","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bfopcu.2014.04.002","volume":"52","author":"Belal S.T.","year":"2014","unstructured":"Belal S.T.; Ahmed M.H.; Mahrous S.M.; Daabees G.H.; Baker M.M.; Validated stability-indicating HPLC-DAD method for determination of the phosphodiesterase (PDE-4) inhibitor roflumilast. Bull Fac Pharm Cairo Univ 2014,52(1),79-89","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jchromb.2012.02.038","volume":"893-894","author":"Knebel N.G.","year":"2012","unstructured":"Knebel N.G.; Herzog R.; Reutter F.; Zech K.; Sensitive quantification of roflumilast and roflumilast N-oxide in human plasma by LC-MS\/MS employing parallel chromatography and electrospray ionisation. J Chromatogr B Analyt Technol Biomed Life Sci 2012,893-894,82-91","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/jms.3103","volume":"47","author":"Thappali S.R.","year":"2012","unstructured":"Thappali S.R.; Varanasi K.V.; Veeraraghavan S.; Vakkalanka S.K.; Mukkanti K.; Simultaneous quantitation of IC87114, roflumilast and its active metabolite roflumilast N-oxide in plasma by LC-MS\/MS: application for a pharmacokinetic study. J Mass Spectrom 2012,47(12),1612-1619","journal-title":"J Mass Spectrom"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jchromb.2016.06.001","volume":"1029-1030","author":"Cui X.","year":"2016","unstructured":"Cui X.; Huang J.; Zheng X.; Jiang J.; Kuang Y.; Hu P.; Simultaneous determination of roflumilast and its metabolite in human plasma by LC-MS\/MS: Application for a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2016,1029-1030,60-67","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/dta.2562","volume":"11","author":"Moussa B.A.","year":"2019","unstructured":"Moussa B.A.; El-Zaher A.A.; El-Ashrey M.K.; Fouad M.A.; Roflumilast analogs with improved metabolic stability, plasma protein binding, and pharmacokinetic profile. Drug Test Anal 2019,11(6),886-897","journal-title":"Drug Test Anal"},{"key":"ref=15","first-page":"274","volume":"4","author":"Patel K.R.","year":"2013","unstructured":"Patel K.R.; Desai D.G.; Zanwar A.; Sen A.K.; Seth A.K.; Development and validat\u0131on of UV spectroscopy method for estimat\u0131on of roflumilast \u0131n bulk and tablet dosage form. Pharma Sci Monitor 2013,4(3),274-280","journal-title":"Pharma Sci Monitor"},{"key":"ref=16","first-page":"369","volume":"2","author":"Ladani J.J.","year":"2012","unstructured":"Ladani J.J.; Bhimani R.D.; Vyas K.B.; Nimavat K.S.; Method development and validation of roflumilast in tablet dosage form by UV spectrophotometry. Journal of Atoms and Molecules 2012,2(5),369-374","journal-title":"Journal of Atoms and Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.21577\/0100-4042.20170371","volume":"42","author":"Guray T.","year":"2019","unstructured":"Guray T.; A New Validated Method For Determinat\u0131on of Roflumilast in Tablet by CZE-UV. Quim Nova 2019,42(5),522-526","journal-title":"Quim Nova"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/157341291601191023100143","volume":"16","author":"Bakirhan N.K.","year":"2020","unstructured":"Bakirhan N.K.; Ozkan S.A.; Recent Advances and Future Perspectives in Pharmaceutical Analysis. Curr Pharm Anal 2020,16(1),2-4","journal-title":"Curr Pharm Anal"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"S1409","DOI":"10.1016\/j.arabjc.2013.04.016","volume":"10","author":"Siddiqui M.R.","year":"2017","unstructured":"Siddiqui M.R.; AlOthman Z.A.; Rahman N.; Analytical techniques in pharmaceutical analysis: A review. Arab J Chem 2017,10,S1409-S1421","journal-title":"Arab J Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1248\/bpb.25.547","volume":"25","author":"Lim C-K.","year":"2002","unstructured":"Lim C-K.; Lord G.; Current developments in LC-MS for pharmaceutical analysis. Biol Pharm Bull 2002,25(5),547-557","journal-title":"Biol Pharm Bull"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00216-010-3741-5","volume":"398","author":"Suntornsuk L.","year":"2010","unstructured":"Suntornsuk L.; Recent advances of capillary electrophoresis in pharmaceutical analysis. Anal Bioanal Chem 2010,398(1),29-52","journal-title":"Anal Bioanal Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1359-6446(03)02846-0","volume":"8","author":"Koh H-L.","year":"2003","unstructured":"Koh H-L.; Yau W-P.; Ong P-S.; Hegde A.; Current trends in modern pharmaceutical analysis for drug discovery. Drug Discov Today 2003,8(19),889-897","journal-title":"Drug Discov Today"},{"key":"ref=23","author":"Watson D.G.","year":"2020","unstructured":"Watson D.G.; Pgce B.P.;  Pharmaceutical analysis E-book: a textbook for pharmacy students and pharmaceutical chemists; Elsevier 2020","journal-title":"Pharmaceutical analysis E-book: a textbook for pharmacy students and pharmaceutical chemists; Elsevier"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/10717544.2018.1455764","volume":"25","author":"Shamsi M.","year":"2018","unstructured":"Shamsi M.; Sedaghatkish A.; Dejam M.; Saghafian M.; Mohammadi M.; Sanati-Nezhad A.; Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy. Drug Deliv 2018,25(1),846-861","journal-title":"Drug Deliv"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1080\/10717544.2018.1497106","volume":"25","author":"Manshadi M.K.D.","year":"2018","unstructured":"Manshadi M.K.D.; Saadat M.; Mohammadi M.; Shamsi M.; Dejam M.; Kamali R.; Sanati-Nezhad A.; Delivery of magnetic micro\/nanoparticles and magnetic-based drug\/cargo into arterial flow for targeted therapy. Drug Deliv 2018,25(1),1963-1973","journal-title":"Drug Deliv"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2230-973X.96920","volume":"2","author":"Tiwari G.","year":"2012","unstructured":"Tiwari G.; Tiwari R.; Sriwastawa B.; Bhati L.; Pandey S.; Pandey P.; Bannerjee S.K.; Drug delivery systems: An updated review. Int J Pharm Investig 2012,2(1),2-11","journal-title":"Int J Pharm Investig"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/156720107782151269","volume":"4","author":"Samad A.","year":"2007","unstructured":"Samad A.; Sultana Y.; Aqil M.; Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007,4(4),297-305","journal-title":"Curr Drug Deliv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2174\/1568026616666161222112305","volume":"17","author":"Tekkeli S.E.K.","year":"2017","unstructured":"Tekkeli S.E.K.; Kiziltas M.V.; Current HPLC methods for assay of nano drug delivery systems. Curr Top Med Chem 2017,17(13),1588-1594","journal-title":"Curr Top Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/1875038901003010056","volume":"3","author":"Dogan-Topal B.","year":"2010","unstructured":"Dogan-Topal B.; Ozkan S.A.; Uslu B.; The analytical applications of square wave voltammetry on pharmaceutical analysis. Open Chemical and Biomedical Methods Journal 2010,3,56-73","journal-title":"Open Chemical and Biomedical Methods Journal"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.talanta.2003.08.034","volume":"62","author":"Dos Santos L.B.","year":"2004","unstructured":"Dos Santos L.B.; Abate G.; Masini J.C.; Determination of atrazine using square wave voltammetry with the Hanging Mercury Drop Electrode (HMDE). Talanta 2004,62(4),667-674","journal-title":"Talanta"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1021\/jf990767e","volume":"48","author":"Romani A.","year":"2000","unstructured":"Romani A.; Minunni M.; Mulinacci N.; Pinelli P.; Vincieri F.F.; Del Carlo M.; Mascini M.; Comparison among differential pulse voltammetry, amperometric biosensor, and HPLC\/DAD analysis for polyphenol determination. J Agric Food Chem 2000,48(4),1197-1203","journal-title":"J Agric Food Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0308-8146(94)P4188-L","volume":"52","author":"Esteve M.","year":"1995","unstructured":"Esteve M.; Farr\u00e9 R.; Frigola A.; L\u00f3pez J.; Romera J.; Ram\u00edrez M.; Gil A.; Comparison of voltammetric and high performance liquid chromatographic methods for ascorbic acid determination in infant formulas. Food Chem 1995,52(1),99-102","journal-title":"Food Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.foodchem.2010.07.047","volume":"124","author":"\u0160eruga M.","year":"2011","unstructured":"\u0160eruga M.; Novak I.; Jakobek L.; Determination of polyphenols content and antioxidant activity of some red wines by differential pulse voltammetry, HPLC and spectrophotometric methods. Food Chem 2011,124(3),1208-1216","journal-title":"Food Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/(SICI)1521-4109(199810)10:15<1043::AID-ELAN1043>3.0.CO;2-V","volume":"10","author":"Alvarez Lueje A.","year":"1998","unstructured":"Alvarez Lueje A.; Pena C.; N\u00fa\u00f1ez Vergara L.J.; Squella J.; Electrochemical study of flutamide, an anticancer drug, and its polarographic, UV spectrophotometric and HPLC determination in tablets. Electroanalysis 1998,10(15),1043-1051","journal-title":"Electroanalysis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0731-7085(00)00382-4","volume":"23","author":"Raggi M.A.","year":"2000","unstructured":"Raggi M.A.; Casamenti G.; Mandrioli R.; Izzo G.; Kenndler E.; Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. J Pharm Biomed Anal 2000,23(6),973-981","journal-title":"J Pharm Biomed Anal"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/713609162","volume":"33","author":"\u00d6zkan S.A.","year":"2003","unstructured":"\u00d6zkan S.A.; Uslu B.; Aboul-Enein H.Y.; Analysis of pharmaceuticals and biological fluids using modern electroanalytical techniques. Crit Rev Anal Chem 2003,33(3),155-181","journal-title":"Crit Rev Anal Chem"},{"key":"ref=37","first-page":"180","author":"Greef R.","year":"1990","unstructured":"Greef R.; Peat R.; Peter L.M.; Pletcher D.; Robinson J.;  Instrumental Methods in Electrochemistry; Ellis Horwood Limited 1990,180-185","journal-title":"Instrumental Methods in Electrochemistry; Ellis Horwood Limited"},{"key":"ref=38","author":"Bard A.J.","year":"1980","unstructured":"Bard A.J.; Faulkner L.R.;  Electrochemical Methods: Fundamentals and Applications; Wiley: New York 1980","journal-title":"Electrochemical Methods: Fundamentals and Applications; Wiley: New York"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-0728(80)80003-9","volume":"112","author":"Laviron E.","year":"1980","unstructured":"Laviron E.; Roullier L.; Degrand C.; A A Multilayer Model for the Study of Space D\u0131str\u0131buted Redox Mod\u0131f\u0131ed Electrodes. 2. Theory and Applicat\u0131on of Linear Potential Sweep Voltammetry For A Simple Reaction. J Electroanal Chem 1980,112(1),11-23","journal-title":"J Electroanal Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1139\/v04-060","volume":"82","author":"Hammam E.","year":"2004","unstructured":"Hammam E.; El-Desoky H.; Tawfik A.; Ghoneim M.; Voltammetric behavior and quantification of the anti-leukemia drug imatinib in bulk form, pharmaceutical formulation, and human serum at a mercury electrode. Can J Chem 2004,82(7),1203-1209","journal-title":"Can J Chem"},{"key":"ref=41","author":"Rix K.","year":"2013","unstructured":"Rix K.;  Electrochemical Reduction of Amides and C=C Bonds; Imperial College: London 2013","journal-title":"Electrochemical Reduction of Amides and C=C Bonds; Imperial College: London"},{"journal-title":"Validation of analytical procedures: text and methodology Q2 (R1)","key":"ref=42","unstructured":"Validation of analytical procedures: text and methodology Q2 (R1) I.C.H."}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/185464","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185464\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/185464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:59:03Z","timestamp":1643453943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185464\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207323666200901102526","relation":{},"ISSN":["1386-2073"],"issn-type":[{"type":"print","value":"1386-2073"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}